(Q41887016)

13 October 2017

0 references

Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis (English)

1 reference

13 October 2017

1 reference

1

1 reference

13 October 2017

Tomenson BM

2

1 reference

PMCID

2549813

13 October 2017

language of work or name

English

0 references

publication date

1 June 1995

1 reference

13 October 2017

1 reference

13 October 2017

310

1 reference

13 October 2017

1433-1438

1 reference

13 October 2017

6992

1 reference

Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability

13 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2549813

Double-blind multicenter study of paroxetine and amitriptyline in depressed inpatients

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2549813

Selective serotonin reuptake inhibitors: meta-analysis of discontinuation rates.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2549813

New or old antidepressants? Benefits of new drugs are exaggerated

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2549813

New or old antidepressants? New is better

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2549813

Antidepressants and suicide

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2549813

The course of manic-depressive illness. A comparative study of bipolar I and bipolar II patients

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2549813

A double-blind comparison of fluvoxamine, imipramine and placebo in depressed patients

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2549813

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2549813

Fluvoxamine and clomipramine in depressed patients. A double-blind clinical study.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2549813

A double-blind placebo-controlled study of fluvoxamine and imipramine in depression.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2549813

A comparative trial of fluoxetine and amitriptyline in patients with major depressive disorder

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2549813

A review of multicenter controlled studies of fluoxetine vs. imipramine and placebo in outpatients with major depressive disorder

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2549813

A double-blind controlled clinical trial of fluoxetine and amitriptyline in the treatment of outpatients with major depressive disorder

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2549813

A comparison of fluoxetine, imipramine, and placebo in patients with major depressive disorder

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2549813

Double-blind comparative trials of fluoxetine and doxepin in geriatric patients with major depressive disorder

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2549813

Meta-analysis in clinical trials

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2549813

A controlled comparison of fluoxetine and amitriptyline in depressed out-patients.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2549813

A comparative trial of a new antidepressant, fluoxetine

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2549813

Fluoxetine, a selective serotonin uptake inhibitor, for the treatment of outpatients with major depression.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2549813

A double-blind comparison of fluvoxamine and dothiepin in the treatment of major affective disorder

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2549813

A comparative clinical trial of fluoxetine, mianserin and placebo in depressed outpatients

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2549813

Fluoxetine versus trazodone in the treatment of outpatients with major depression.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2549813

A double-blind study of fluoxetine and imipramine in major depression.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2549813

Efficacy and tolerability of fluoxetine in the elderly: a double-blind study versus amitryptiline

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2549813

A double-blind comparative study of fluoxetine and dothiepin in the treatment of depression in general practice.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2549813

The short- and long-term efficacy of paroxetine HCl: A. Data from a 6-week double-blind parallel design trial vs. imipramine and placebo

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2549813

The therapeutic efficacy of paroxetine: (a) an open study in patients with major depression not responding to antidepressants; (b) a double-blind comparison with amitriptyline in depressed outpatients.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2549813

Paroxetine in the treatment of depression: a comparison with imipramine and placebo

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2549813

Double-blind, multicenter comparison of sertraline and amitriptyline in elderly depressed patients

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2549813

Antidepressant efficacy of sertraline: a double-blind, placebo- and amitriptyline-controlled, multicenter comparison study in outpatients with major depression

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2549813

A placebo- and imipramine-controlled study of paroxetine

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2549813

A double-blind, randomized comparison of fluvoxamine with mianserin in depressive illness

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2549813

A comparison of fluoxetine and amitriptyline in the treatment of major depression.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2549813

Suicide and panic disorder: a review

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2549813

Paroxetine and imipramine treatment of depressive patients in a controlled multicentre study with plasma amino acid measurements

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2549813

Meta-analysis. Part 2: Assessing the quality of published meta-analyses

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2549813

Two combined, multicenter double-blind studies of paroxetine and doxepin in geriatric patients with major depression

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2549813

Paroxetine and imipramine in the treatment of depressive patients in psychiatric practice

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2549813

Recognition and management of depression in general practice: consensus statement

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2549813

Sleep and paroxetine: a comparison with mianserin in elderly depressed patients

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2549813

A double-blind comparison of paroxetine, imipramine and placebo in depressed outpatients

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2549813

Comparative efficacy of antidepressants

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2549813

Depression: treatment compliance in general practice.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2549813

A double-blind comparison of citalopram (Lu 10-171) and amitriptyline in depressed patients

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2549813

A double-blind study of the comparative antidepressant effect of paroxetine and amitriptyline

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2549813

A placebo-controlled inpatient comparison of fluvoxamine maleate and imipramine in major depression.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2549813

The role of neuropharmacologic selectivity in antidepressant action: fluvoxamine versus desipramine

18 August 2018

1 reference

12 December 2020

Fluvoxamine and imipramine in the treatment of depressive patients: a double-blind controlled study

1 reference

12 December 2020

A double-blind comparison of fluvoxamine, desipramine and placebo in outpatients with depression

1 reference

12 December 2020

Paroxetine in the treatment of depression--a randomized comparison with amitriptyline

1 reference

12 December 2020

Double-blind comparative study of paroxetine and amitriptyline in depressed patients of a university psychiatric outpatient clinic (pilot study)

1 reference

12 December 2020

A double-blind comparison of fluoxetine, imipramine and placebo in outpatients with major depression

1 reference

12 December 2020

A comparative trial of fluoxetine versus trazodone in outpatients with major depression

1 reference

12 December 2020

Fluvoxamine, imipramine, and placebo in the treatment of depressed outpatients: effects on depression

1 reference

12 December 2020

A double-blind, multicentre study of paroxetine versus clomipramine in depressed elderly patients

1 reference

12 December 2020

A double-blind clinical trial of fluvoxamine and imipramine in patients with primary depression

1 reference

12 December 2020

Fluoxetine in depressed patients: a comparison with imipramine

1 reference

12 December 2020

Treatment of major affective disorder with fluvoxamine

1 reference

12 December 2020

Paroxetine in the treatment of depression. A double-blind multicenter study versus mianserin

1 reference

12 December 2020

A comparative trial of a new antidepressant, fluoxetine

1 reference

12 December 2020

Fluoxetine 40 mg vs maprotiline 75 mg in the treatment of out-patients with depressive disorders

1 reference

12 December 2020

A double-blind parallel study to compare fluoxetine with doxepin in the treatment of major depressive disorders

1 reference

12 December 2020

Fluoxetine versus nomifensine in outpatients with neurotic or reactive depressive disorder

1 reference

12 December 2020

Fluoxetine versus imipramine

1 reference

12 December 2020

Randomized double-blind study of fluvoxamine and maprotiline in treatment of depression

1 reference

12 December 2020

Comparative efficacy and safety of nortriptyline and fluoxetine in the treatment of major depression: a clinical study

1 reference

12 December 2020

A Randomized, Double-Blind Study of Fluoxetine and Maprotiline in the Treatment of Major Depression

1 reference

12 December 2020

Double-blind comparison of bupropion and fluoxetine in depressed outpatients

1 reference

12 December 2020

Double-blind comparative multicentre study of fluvoxamine and mianserin in the treatment of major depressive episode in elderly people

1 reference

12 December 2020

A Comparison of Paroxetine, Imipramine and Placebo in Depressed Out-patients

1 reference

12 December 2020

A double-blind, randomised comparison of fluvoxamine with dothiepin in the treatment of depression in elderly patients

1 reference

12 December 2020

A double-blind multicentre study of paroxetine and amitriptyline in depressed outpatients. Italian Paroxetine Study Group

1 reference

12 December 2020

Perspectives in clinical psychopharmacology of amitriptyline and fluvoxamine. A double-blind study in depressed inpatients

1 reference

12 December 2020

A Multicentre Double Blind Trial of Fluoxetine versus Amitriptyline in the Treatment of Depressive Illness

1 reference

12 December 2020

A comparison of fluoxetine and imipramine in the treatment of outpatients with major depressive disorder

1 reference

12 December 2020

A study comparing paroxetine placebo and imipramine in depressed patients

1 reference

12 December 2020

What price depression? The cost of depression and the cost-effectiveness of pharmacological treatment

1 reference

12 December 2020

Clinically useful measures of effect in binary analyses of randomized trials

1 reference

12 December 2020

Fluvoxamine maleate, a serotonergic antidepressant; a comparison with chlorimipramine

1 reference

12 December 2020

Double-blind controlled study on the clinical efficacy and safety of fluoxetine vs clomipramine in the treatment of major depressive disorders

1 reference

12 December 2020

Fluoxetine versus clomipramine in major depressive disorders

1 reference

12 December 2020

Fluoxetine versus amineptine in the treatment of outpatients with major depressive disorders

1 reference

12 December 2020

Fluoxetine vs amitriptyline in the treatment of depressed out-patients

1 reference

12 December 2020

A double-blind study to compare the effectiveness and tolerability of paroxetine and amitriptyline in depressed patients

1 reference

12 December 2020

Fluoxetine Versus Trazodone in Depressed Geriatric Patients

1 reference

12 December 2020

A double-blind, placebo-controlled trial of fluvoxamine versus imipramine in outpatients with major depression

1 reference

12 December 2020

10.1136/BMJ.310.6992.1433

Identifiers

DOI

1 reference

13 October 2017

1 reference

13 October 2017

1 reference

PMCID

2549813